Flexion Therapeutics Analysis
Flexion Therapeutics is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Flexion Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Flexion Therapeutics is worth, separate from its market price. There are two main types of Flexion Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Flexion Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Flexion Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Flexion Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Flexion Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Flexion Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Flexion Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Flexion |
Flexion Stock Analysis Notes
About 92.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.2. Flexion Therapeutics had not issued any dividends in recent years. Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. Flexion Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 257 people. To learn more about Flexion Therapeutics call Michael Clayman at 781 305-7777 or check out www.flexiontherapeutics.com.Flexion Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Flexion Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Flexion Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Flexion Therapeutics is not yet fully synchronised with the market data | |
| Flexion Therapeutics has some characteristics of a very speculative penny stock | |
| Flexion Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 102.74 M. Net Loss for the year was (95.05 M) with profit before overhead, payroll, taxes, and interest of 66.53 M. | |
| Flexion Therapeutics currently holds about 131.43 M in cash with (59.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.61. | |
| Over 92.0% of the company shares are owned by institutional investors |
Flexion Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 455.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Flexion Therapeutics's market, we take the total number of its shares issued and multiply it by Flexion Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Flexion Profitablity
Flexion Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Flexion Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Flexion Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Flexion Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Flexion Therapeutics' profitability requires more research than a typical breakdown of Flexion Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (92.52) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (71.24) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $71.24.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Flexion Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Flexion Stock
If you are still planning to invest in Flexion Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Flexion Therapeutics' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |